Latest News about BMRN
Recent news which mentions BMRN
FDA Battles Backlog of Drug Factory Inspections Since COVID-19
September 06, 2024
From Benzinga
BioMarin Restructures, Outlines Roadmap To $4B Revenues By 2027
September 05, 2024
From Benzinga
Ascendis Pharma Faces Challenges With Skytrofa And Yorvipath Pricing: Analysts Weigh In
September 04, 2024
From Benzinga
(BMRN) - Analyzing Biomarin Pharmaceutical's Short Interest
August 21, 2024
Tickers
BMRN
From Benzinga
Palo Alto Networks To Rally More Than 16%? Here Are 10 Top Analyst Forecasts For Tuesday
August 20, 2024
From Benzinga
$1000 Invested In Biomarin Pharmaceutical 20 Years Ago Would Be Worth This Much Today
August 07, 2024
From Benzinga
Rare Disease-Focused BioMarin Narrows Sales Focus, Cuts Cost For Hemophilia A Gene Therapy; Lifts Annual Guidance
August 06, 2024
From Benzinga
Yum China Posts Upbeat Earnings, Joins Clear Secure, TG Therapeutics, Bioventus And Other Big Stocks Moving Higher On Tuesday
August 06, 2024
From Benzinga
Biomarin Pharmaceutical Analysts Boost Their Forecasts Following Better-Than-Expected Q2 Results
August 06, 2024
From Benzinga
Tickers
BMRN
From InvestorPlace
From Benzinga
From Benzinga
From InvestorPlace
10 Health Care Stocks Whale Activity In Today's Session
June 04, 2024
From Benzinga
From Benzinga
From Motley Fool
From Benzinga
From Benzinga
The 3 Best Biotech Stocks to Buy in May 2024
May 09, 2024
From InvestorPlace
Citi Just Cut Its Price Target on These 3 Stocks
May 03, 2024
From InvestorPlace
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.